Literature DB >> 33731754

Antibodies against EGF-like domains in Ixodes scapularis BM86 orthologs impact tick feeding and survival of Borrelia burgdorferi.

Juraj Koči1,2,3, Sandhya Bista4, Payal Chirania4, Xiuli Yang4, Chrysoula Kitsou4, Vipin Singh Rana4, Ozlem Buyuktanir Yas5, Daniel E Sonenshine6, Utpal Pal7,8.   

Abstract

Ixodes scapularis ticks transmit multiple pathogens, including Borrelia burgdorferi sensu stricto, and encode many proteins harboring epidermal growth factor (EGF)-like domains. We show that I. scapularis produces multiple orthologs for Bm86, a widely studied tick gut protein considered as a target of an anti-tick vaccine, herein termed as Is86. We show that Is86 antigens feature at least three identifiable regions harboring EGF-like domains (termed as EGF-1, EGF-2, and EGF-3) and are differentially upregulated during B. burgdorferi infection. Although the RNA interference-mediated knockdown of Is86 genes did not show any influences on tick engorgement or B. burgdorferi sensu stricto persistence, the immunization of murine hosts with specific recombinant EGF antigens marginally reduced spirochete loads in the skin, in addition to affecting tick blood meal engorgement and molting. However, given the borderline impact of EGF immunization on tick engorgement and pathogen survival in the vector, it is unlikely that these antigens, at least in their current forms, could be developed as potential vaccines. Further investigations of the biological significance of Is86 (and other tick antigens) would enrich our knowledge of the intricate biology of ticks, including their interactions with resident pathogens, and contribute to the development of anti-tick measures to combat tick-borne illnesses.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33731754      PMCID: PMC7971074          DOI: 10.1038/s41598-021-85624-5

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  49 in total

Review 1.  Vaccination against ticks (Boophilus spp.): the experience with the Bm86-based vaccine Gavac.

Authors:  J de la Fuente; M Rodríguez; C Montero; M Redondo; J C García-García; L Méndez; E Serrano; M Valdés; A Enríquez; M Canales; E Ramos; O Boué; H Machado; R Lleonart
Journal:  Genet Anal       Date:  1999-11

2.  Molecular analysis of the epidermal growth factor-like short consensus repeat domain-mediated protein-protein interactions: dissection of the CD97-CD55 complex.

Authors:  H H Lin; M Stacey; C Saxby; V Knott; Y Chaudhry; D Evans; S Gordon; A J McKnight; P Handford; S Lea
Journal:  J Biol Chem       Date:  2001-04-10       Impact factor: 5.157

3.  Human epidermal growth factor (EGF) module-containing mucin-like hormone receptor 3 is a new member of the EGF-TM7 family that recognizes a ligand on human macrophages and activated neutrophils.

Authors:  M Stacey; H H Lin; K L Hilyard; S Gordon; A J McKnight
Journal:  J Biol Chem       Date:  2001-03-14       Impact factor: 5.157

4.  Cloning and expression of a protective antigen from the cattle tick Boophilus microplus.

Authors:  K N Rand; T Moore; A Sriskantha; K Spring; R Tellam; P Willadsen; G S Cobon
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

5.  Evolution of distinct EGF domains with specific functions.

Authors:  Merridee A Wouters; Isidore Rigoutsos; Carmen K Chu; Lina L Feng; Duncan B Sparrow; Sally L Dunwoodie
Journal:  Protein Sci       Date:  2005-04       Impact factor: 6.725

Review 6.  Tick control: thoughts on a research agenda.

Authors:  Peter Willadsen
Journal:  Vet Parasitol       Date:  2006-02-23       Impact factor: 2.738

7.  Development of a foundation for a case definition of post-treatment Lyme disease syndrome.

Authors:  John N Aucott; Lauren A Crowder; Kathleen B Kortte
Journal:  Int J Infect Dis       Date:  2013-02-23       Impact factor: 3.623

Review 8.  Anti-tick vaccines in the omics era.

Authors:  Manuel Rodriguez Valle; Felix D Guerrero
Journal:  Front Biosci (Elite Ed)       Date:  2018-01-01

9.  A chromosomally encoded virulence factor protects the Lyme disease pathogen against host-adaptive immunity.

Authors:  Xiuli Yang; Adam S Coleman; Juan Anguita; Utpal Pal
Journal:  PLoS Pathog       Date:  2009-03-06       Impact factor: 6.823

10.  Borrelia burgdorferi surface protein Lmp1 facilitates pathogen dissemination through ticks as studied by an artificial membrane feeding system.

Authors:  Juraj Koci; Quentin Bernard; Xiuli Yang; Utpal Pal
Journal:  Sci Rep       Date:  2018-01-30       Impact factor: 4.379

View more
  1 in total

Review 1.  Past, present, and future of Lyme disease vaccines: antigen engineering approaches and mechanistic insights.

Authors:  Wen-Hsiang Chen; Ulrich Strych; Maria Elena Bottazzi; Yi-Pin Lin
Journal:  Expert Rev Vaccines       Date:  2022-07-22       Impact factor: 5.683

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.